Search Results 1171-1180 of 21697 for Inhibition

1. Alfonso Eirin Massat, M.D. - Mayo Clinic Faculty Profiles

   ... inhibition of protein translation by interaction of microRNAs with their target mRNAs. Significance to patient care. The work in Dr. Eirin's laboratory has ...

2. Cetuximab With or Without Tivantinib in Treating Patients With Head and Neck Cancer That Is Recurrent, Metastatic, or Cannot Be Removed By Surgery - Mayo Clinic

   Patients who have received treatment with an EGFR or MET inhibitor in the palliative treatment setting are ineligible; Patients with known, active brain ...

3. A Study of Patients with Relapsed or Refractory Acute Myeloid Leukemia (AML) with MCL-1 Dependence ≥ 40% - Mayo Clinic

   Participation eligibility · Received more than 2 cycles of induction therapy for AML. · Received any previous treatment with alvocidib or any other CDK inhibitor.

4. Losartan for Outpatients on COVID-19 - Clinical Trials

   ... inhibitor (ACEi) or Angiotensin receptor blocker (ARB). Prior reaction or intolerance to an ARB or ACE inhibitor, including but not limited to angioedema.

5. PD 0332991 and Anastrozole for Stage 2 or 3 Estrogen Receptor Positive and HER2 Negative Breast Cancer - Mayo Clinic

   ... inhibitors, 2) result in fewer patients with on therapy Ki67>10% compared to historical control. Participation eligibility. Participant eligibility includes ...

6. Elagolix, estradiol, and norethindrone (oral route) - Side effects & dosage - Mayo Clinic

   If a pregnancy occurs while using the medicine, tell your doctor right away. Do not use this medicine together with medicines called OATP 1B1 inhibitors that ...

7. Atypical antidepressants - Mayo Clinic

   Selective serotonin reuptake inhibitors (SSRIs) · Serotonin and norepinephrine reuptake inhibitors (SNRIs) · Sleep tips · Soy: Does it worsen hypothyroidism ...

8. Publications - William G. Breen, M.D. - Mayo Clinic

   The novel brain penetrant ATM inhibitor WSD0628 provides robust radiosensitization of brain tumor patient derived xenografts. ... inhibitors. Radiother ...

9. Screening Study For KIT D816V Mutated Mast Cell Disease In Select Populations - Mayo Clinic

   Current or previous treatment (including investigational treatments) with selective KIT D816V inhibitors. Any prior or ongoing clinically significant ...

10. Safety and Efficacy of B-cell Activating Factor Receptor (BAFFR)-based Chimeric Antigen Receptor T-cells in Subjects with Relapsed or Refractory BAFFR-expressing B-cell Hematologic Malignancies - Mayo Clinic

    For CLL/SLL, patients must have received prior therapies, namely a BTK inhibitor or BCL-2 inhibitor. These patients may or may not have received prior ...